Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

Delayed Data
As of Feb 11
 +1.87 / +1.56%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 170.50, with a high estimate of 244.00 and a low estimate of 102.00. The median estimate represents a +40.20% increase from the last price of 121.61.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -71.97%
Growthannually 109.60%


Growthquarterly -0.12%
Growthannually 12.26%
Key to the earnings and sales forecast charts.